BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai Z, Wu J, Chen F, Cheng Q, Zhang M, Wang Y, Guo Y, Song T. CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners. Oncol Rep. 2016;36:3303-3310. [PMID: 27748886 DOI: 10.3892/or.2016.5155] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu B, Fan H, Lv X, Chen S, Shao Z. Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis. Cancer Cell Int. 2018;18:68. [PMID: 29743818 DOI: 10.1186/s12935-018-0562-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
2 Novillo A, Gaibar M, Romero-Lorca A, Gilsanz MF, Beltrán L, Galán M, Antón B, Malón D, Moreno A, Fernández-Santander A. Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports. World J Gastroenterol 2020;26:1979-86. [PMID: 32390708 DOI: 10.3748/wjg.v26.i16.1979] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Zhang W, Wang H, Sun M, Deng X, Wu X, Ma Y, Li M, Shuoa SM, You Q, Miao L. CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target. Cancer Commun (Lond) 2020;40:69-80. [PMID: 32237072 DOI: 10.1002/cac2.12010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
4 Mu P, Liu K, Lin Q, Yang W, Liu D, Lin Z, Shao W, Ji T. Sirtuin 7 promotes glioma proliferation and invasion through activation of the ERK/STAT3 signaling pathway. Oncol Lett 2019;17:1445-52. [PMID: 30675198 DOI: 10.3892/ol.2018.9800] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
5 Liu X, Chang X, Leng S, Tang H, Aihara K, Chen L. Detection for disease tipping points by landscape dynamic network biomarkers. National Science Review 2019;6:775-85. [DOI: 10.1093/nsr/nwy162] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 11.3] [Reference Citation Analysis]
6 Bi CL, Liu JF, Zhang MY, Lan S, Yang ZY, Fang JS. LncRNA NEAT1 promotes malignant phenotypes and TMZ resistance in glioblastoma stem cells by regulating let-7g-5p/MAP3K1 axis. Biosci Rep 2020;40:BSR20201111. [PMID: 33057597 DOI: 10.1042/BSR20201111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Li S, Ou Y, Liu S, Yin J, Zhuo W, Huang M, Zhu T, Zhang W, Zhou H, Liu Z. The Fibroblast TIAM2 Promotes Lung Cancer Cell Invasion and Metastasis. J Cancer 2019;10:1879-89. [PMID: 31205545 DOI: 10.7150/jca.30477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yin X, Zhang Y, Wen Y, Yang Y, Chen H. Celecoxib alleviates zinc deficiency-promoted colon tumorigenesis through suppressing inflammation. Aging (Albany NY) 2021;13:8320-34. [PMID: 33686969 DOI: 10.18632/aging.202642] [Reference Citation Analysis]
9 Li Y, Wu T, Gong S, Zhou H, Yu L, Liang M, Shi R, Wu Z, Zhang J, Li S. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma. Front Oncol 2020;10:570736. [PMID: 33489879 DOI: 10.3389/fonc.2020.570736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Layhadi JA, Turner J, Crossman D, Fountain SJ. ATP Evokes Ca2+ Responses and CXCL5 Secretion via P2X4 Receptor Activation in Human Monocyte-Derived Macrophages. J Immunol 2018;200:1159-68. [PMID: 29255078 DOI: 10.4049/jimmunol.1700965] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 9.3] [Reference Citation Analysis]
11 Hübner M, Moellhoff N, Effinger D, Hinske CL, Hirschberger S, Wu T, Müller MB, Strauß G, Kreth FW, Kreth S. MicroRNA-93 acts as an "anti-inflammatory tumor suppressor" in glioblastoma. Neurooncol Adv 2020;2:vdaa047. [PMID: 32642700 DOI: 10.1093/noajnl/vdaa047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Cao F, Fan Y, Yu Y, Yang G, Zhong H. Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis. Cancer Manag Res 2021;13:5477-89. [PMID: 34267555 DOI: 10.2147/CMAR.S310346] [Reference Citation Analysis]
13 Hawkins CC, Ali T, Ramanadham S, Hjelmeland AB. Sphingolipid Metabolism in Glioblastoma and Metastatic Brain Tumors: A Review of Sphingomyelinases and Sphingosine-1-Phosphate. Biomolecules 2020;10:E1357. [PMID: 32977496 DOI: 10.3390/biom10101357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Giuliano S, Dufies M, Ndiaye PD, Viotti J, Borchiellini D, Parola J, Vial V, Cormerais Y, Ohanna M, Imbert V, Chamorey E, Rioux-Leclercq N, Savina A, Ferrero JM, Mograbi B, Pagès G. Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5. Theranostics 2019;9:1181-99. [PMID: 30867824 DOI: 10.7150/thno.29093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
15 Yu M, Ma X, Jiang D, Wang L, Zhan Q, Zhao J. CXC chemokine ligand 5 (CXCL5) disrupted the permeability of human brain microvascular endothelial cells via regulating p38 signal. Microbiol Immunol 2021;65:40-7. [PMID: 33026667 DOI: 10.1111/1348-0421.12854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Manini I, Caponnetto F, Dalla E, Ius T, Della Pepa GM, Pegolo E, Bartolini A, La Rocca G, Menna G, Di Loreto C, Olivi A, Skrap M, Sabatino G, Cesselli D. Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways. Cancers (Basel) 2020;12:E2960. [PMID: 33066172 DOI: 10.3390/cancers12102960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Tong X, Yang P, Wang K, Liu Y, Liu X, Shan X, Huang R, Zhang K, Wang J. Survivin is a prognostic indicator in glioblastoma and may be a target of microRNA-218. Oncol Lett 2019;18:359-67. [PMID: 31289507 DOI: 10.3892/ol.2019.10335] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Guo XY, Zhang GH, Wang ZN, Duan H, Xie T, Liang L, Cui R, Hu HR, Wu Y, Dong JJ, He ZQ, Mou YG. A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling. Aging (Albany NY) 2021;13:3501-17. [PMID: 33429364 DOI: 10.18632/aging.202282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kim Y, Lee D, Lawler S. Collective invasion of glioma cells through OCT1 signalling and interaction with reactive astrocytes after surgery. Philos Trans R Soc Lond B Biol Sci 2020;375:20190390. [PMID: 32713306 DOI: 10.1098/rstb.2019.0390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Zhang R, Liu Q, Peng J, Wang M, Li T, Liu J, Cui M, Zhang X, Gao X, Liao Q, Zhao Y. CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration. J Cancer 2020;11:2371-81. [PMID: 32201508 DOI: 10.7150/jca.40517] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
21 Wang B, Wu ZS, Wu Q. CMIP Promotes Proliferation and Metastasis in Human Glioma. Biomed Res Int 2017;2017:5340160. [PMID: 28744466 DOI: 10.1155/2017/5340160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
22 Qiu WZ, Zhang HB, Xia WX, Ke LR, Yang J, Yu YH, Liang H, Huang XJ, Liu GY, Li WZ, Xiang YQ, Kang TB, Guo X, Lv X. The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling. J Exp Clin Cancer Res 2018;37:85. [PMID: 29665837 DOI: 10.1186/s13046-018-0722-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]